Skip to main content
Premium Trial:

Request an Annual Quote

Accelerate Diagnostics Files $150M Shelf Registration

NEW YORK (GenomeWeb News) – Accelerate Diagnostics has filed a shelf registration to publicly offer from time to time up to $150 million of securities.

In a Form S-3 filed with the US Securities and Exchange Commission on Wednesday, the company said that it may offer common stock, preferred stock, debt securities, warrants, and/or units in combination. Net proceeds from any offering will go toward general corporate purposes.

During the summer, Accelerate said that it raised $20 million in a rights offering. Last week, it disclosed in an SEC filing a year over year increase in its third quarter revenues.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.